Moderna Wins EU Nod for Covid-Flu Combo Shot Stalled in US (2)

European regulators gave the green light to Moderna Inc.’s novel combination flu and Covid shot, handing a victory to the embattled vaccine maker as it struggles to get the same shot approved in the US.

The European Medicines Agency’s human medicines committee issued a positive opinion on Friday for the shot, which uses messenger RNA technology, for adults 50 and older. It’s the first nod for a vaccine to protect against both respiratory diseases in a single dose.

The committee pointed to the benefit of only having one vaccine for two infections in a statement. There have ...